Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

XDx

- PMLiVE

Alcon spin-off prompts Novartis downgrade by Moody’s

Selling off Alcon concentrates business in riskier areas

- PMLiVE

Pharma industry appointments

Destiny Pharma, Silence Therapeutics and Concept Life Sciences add to its teams.

- PMLiVE

CAR-Ts Kymriah and Yescarta step closer to approval in Europe

Final European approval around the corner - but reimbursement and specialist centres among outstanding issues

- PMLiVE

Healthcare comms appointments

Lucid Group, Wilmington Healthcare and Galliard Healthcare add to their teams

- PMLiVE

Johnson and Johnson’s second-in-command announces retirement plans

Sandra Peterson departs at the start of October

- PMLiVE

Weekly comms appointments

Axon promotes team members

Sanofi reception

Sanofi poaches Peugeot’s finance head

Jean-Baptiste Chasseloup de Chatillon joins the French drugmaker as chief financial officer

- PMLiVE

New trial results suggest CAR-T effects are durable in lymphoma

Novartis and Celgene/Juno release longer term data on important lymphoma indication at EHA

- PMLiVE

Paris biocluster appoints Stéphane Roques as new chief

Former general manager for Emmanuel Macron's party to spearhead Paris' bid to attract life sciences investment

Weekly comms appointments

Publicis Resolute, Road and W2O all add to their teams

- PMLiVE

Health Unlimited bolsters PR team

Appoints Ann Bartling as PR practice lead

- PMLiVE

GSK’s vaccines president Debruyne heads for the exit

Roger Connor to take on the role in latest shake up

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links